Stay updated on AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC
Sign up to get notified when there's something new on the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page.

Latest updates to the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the study record history. The funding lapse notice and Revision: v3.4.1 entry were removed.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide maintenance notice about government funding and operating status, and updated the revision label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe new screenshot shows UI updates such as a glossary toggle and color-coded highlights (green for additions, red for deletions) with the revision label updated from v3.3.4 to v3.4.0. These changes are cosmetic and do not modify study data or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the Record History, and the previous entry v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, v3.3.3, was added to the history. The deletion list now excludes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check71 days agoChange DetectedThe study record history now includes new sections for Contacts/Locations, Outcome Measures, Arms and Interventions, Conditions, and Study Status, with updates on 2025-12-10 and 2025-12-04.SummaryDifference0.7%

Stay in the know with updates to AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC
Enter your email address, and we'll notify you when there's something new on the AVANZAR Clinical Trial: Dato-DXd Combo in NSCLC page.